...
首页> 外文期刊>Der Pharmacia Lettre >Development and validation of spectrophotometric methods for simultaneous estimation of Paracetamol and Meloxicam in pure and tablet dosage form
【24h】

Development and validation of spectrophotometric methods for simultaneous estimation of Paracetamol and Meloxicam in pure and tablet dosage form

机译:分光光度法同时估算纯和片剂剂型对乙酰氨基酚和美洛昔康的开发和验证

获取原文
           

摘要

Two simple, accurate, economical and reproducible spectrophotometric methods for simultaneous estimation of paracetamol and meloxicam in pure and tablet dosage form have been developed. Method I is based on solving simultaneous equation. Paracetamol and meloxicam show absorbance maximums at 256 and 268.8 nm so absorbance was measured at the same wave lengths for the estimation of paracetamol and meloxicam. Method II is based on determination of Q-value. Absorbance was measured at 308 nm (Isobestic point) and 256 nm (λmax of paracetamol). Both drugs obey the Beer Lambert's law in the concentration range of 5- 30 μg /mL. Methods are validated according to ICH guidelines and can be adopted for the routine analysis of paracetamol and meloxicam in pure and tablet dosage form.
机译:开发了两种简单,准确,经济和可重现的分光光度法,可同时估算纯和片剂剂型中对乙酰氨基酚和美洛昔康。方法I基于求解联立方程。扑热息痛和美洛昔康在256和268.8 nm处显示最大吸收,因此在相同波长下测量吸光度以估算扑热息痛和美洛昔康。方法II基于Q值的确定。在308nm(等渗点)和256nm(对乙酰氨基酚的λmax)处测量吸光度。两种药物在5至30μg/ mL的浓度范围内均符合比尔·朗伯定律。方法已按照ICH指南进行了验证,可用于对乙酰氨基酚和美洛昔康的纯品和片剂剂型的常规分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号